Pnc Financial Services »

Actuate Therapeutics shares owned by Pnc Financial Services

Quarter-by-quarter ownership of Actuate Therapeutics (ACTU) shares owned by Pnc Financial Services from 13F filings

Historical chart of Pnc Financial Services investment in Actuate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Actuate Therapeutics held by Pnc Financial Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Actuate Therapeutics by Pnc Financial Services

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.6k 384 6.69

More positions owned by Pnc Financial Services

Eli Lilly & Co. (LLY)
Ishares Tr Core S&p500 Et (IVV)
Apple (AAPL)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Broadcom (AVGO)
Erie Indty Cl A (ERIE)
Amazon (AMZN)
Ishares Tr Rus 1000 Grw E (IWF)
Ishares Tr Core Msci Eafe (IEFA)
Wisdomtree Tr Us Qtly Div Gr (DGRW)

View all positions for Pnc Financial Services

Top funds holding Actuate Therapeutics

BIOS Capital Management
Voss Capital
Vanguard Group
BlackRock
Geode Capital Management
Northern Trust
State Street Corporation
Northwestern Mutual Wealth Management Company
Gleason Group
SFMG Wealth Advisors
LPL Financial
Charles Schwab Investment Management
Wells Fargo & Company
Royal Bank of Canada
Freestone Capital Holdings

View all funds holding Actuate Therapeutics